Green Thumb Industries Inc
General ticker "GTBIF" information:
- Sector: Health Care
- Industry: Pharmaceuticals
- Capitalization: $2.0B
Green Thumb Industries Inc does not follow the US Stock Market performance with the rate: -33.3%.
Estimated limits based on current volatility of 2.5%: low 7.64$, high 8.03$
Factors to consider:
- Price in estimated range
- Earnings for 9 months up through Q3 exceed our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2023-12-31 to 2025-12-30
- 2023-12-31 to 2024-12-30 estimated range: [7.41$, 14.47$]
- 2024-12-30 to 2025-12-30 estimated range: [7.78$, 14.98$]
Financial Metrics affecting the GTBIF estimates:
- Positive: 0.10 < Non-GAAP EPS, $ of 0.15
- Positive: 9.05 < Operating profit margin, % of 17.51
- Negative: Industry earnings per price (median), % of -15.01 <= 1.31
- Negative: Industry operating cash flow per share per price (median), % of -12.63 <= 3.85
- Positive: Interest expense per share, $ of 0.08 <= 0.14
- Positive: -3.48 < Investing cash flow per share, $ of -0.96
- Positive: 7.18 < Operating cash flow per share per price, % of 8.95
Short-term GTBIF quotes
Long-term GTBIF plot with estimates
Financial data
| YTD | 2021-12-31 | 2022-12-31 | 2023-12-31 |
|---|---|---|---|
| Operating Revenue | $893.56MM | $1,017.38MM | $1,054.55MM |
| Operating Expenses | $678.72MM | $896.31MM | $869.92MM |
| Operating Income | $214.84MM | $121.06MM | $184.63MM |
| Non-Operating Income | $-9.87MM | $-12.63MM | $-28.58MM |
| Interest Expense | $21.98MM | $21.20MM | $19.07MM |
| Income(Loss) | $204.97MM | $108.43MM | $156.05MM |
| Taxes | $124.61MM | $94.78MM | $119.78MM |
| Other Income(Loss) | $-4.93MM | $-1.68MM | $0.00MM |
| Profit(Loss) | $75.44MM | $11.98MM | $36.27MM |
| Stockholders Equity | $1,621.12MM | $1,664.92MM | $1,702.88MM |
| Inventory | $95.47MM | $115.67MM | $112.97MM |
| Assets | $2,385.85MM | $2,433.53MM | $2,490.06MM |
| Operating Cash Flow | $132.05MM | $158.56MM | $224.97MM |
| Capital expenditure | $187.85MM | $179.50MM | $220.03MM |
| Investing Cash Flow | $-280.73MM | $-219.95MM | $-227.91MM |
| Financing Cash Flow | $295.34MM | $8.64MM | $-13.11MM |
| Earnings Per Share* | $0.33 | $0.05 | $0.15 |
* EPS are Split Adjusted, recent splits may be reflected with a delay.